Search results
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
Morningstar· 5 days agoOn track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion's next generation supercomputer, ...
Q1 2024 Matinas BioPharma Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoWhile we work to secure MAT2203 future. We are grateful to our new investors for their support. Keith? Keith Kucinski Thank you, Jerry, and good afternoon. In reviewing our financial performance ...
JD Supra: Biomedical Device Consultants and Laboratories of Colorado, LLC v. Vivitro Labs, Inc.
JD Supra· 6 days agoA preliminary injunction is one of the most potent weapons in a patent plaintiff's arsenal, being capable of shutting down an accused infringer's continued infringement, prohibiting the infringing ...
Curis to Present Updated Data from the TakeAim Leukemia Study
WPRI Providence· 4 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Adaptive Biotechnologies Expects Growth From FDA Panel MRD Vote, Cuts Staff by 7 Percent in Q1
GenomeWeb News· 6 days agoAdaptive Biotechnologies' management this week outlined several potential gains for the company's minimal residual disease (MRD) business in light of the recent news that a US Food and Drug ...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Proj
Guru Focus· 4 days agoOn May 9, 2024, Lineage Cell Therapeutics Inc (LCTX, Financial) disclosed its financial results for the first quarter of 2024 through an 8-K filing. The clinical-stage biotechnology company, ...
